EPS for AC Immune Ltd (ACIU) Expected At $-0.17, Westbury Bancorp (WBB) Has 1.33 Sentiment

June 2, 2017 - By Dolores Ford

Westbury Bancorp, Inc. is the savings and loan holding firm for Westbury Bank . The company has market cap of $82.28 million. The Bank is a federally chartered savings bank. It has a 24.58 P/E ratio. As of September 30, 2016, the Company conducted its business through its office located in West Bend, Wisconsin, seven branch offices in West Bend, Brookfield, Germantown, Hartford, Jackson, Kewaskum and Slinger, Wisconsin, and loan production offices in Madison and Appleton, Wisconsin.

Analysts expect AC Immune Ltd (NASDAQ:ACIU) to report $-0.17 EPS on June, 16. The stock decreased 0.90% or $0.08 on June 1, reaching $8.82. About shares traded. AC Immune Ltd (NASDAQ:ACIU) has 0.00% since June 2, 2016 and is . It has underperformed by 16.70% the S&P500.

AC Immune Ltd is a Switzerland-based firm engaged in the medical biotechnology sector. The company has market cap of $504.36 million. It develops treatments for Alzheimer’s and other neurodegenerative diseases, such as Down syndrome, glaucoma and Parkinson’s, and focuses on producing therapeutic and diagnostic product candidates, using SupraAntigen and Morphomer technology platforms. It currently has negative earnings.

Since January 1, 0001, it had 9 insider buys, and 0 selling transactions for $165,730 activity.

Seidman Lawrence B holds 1.57% of its portfolio in Westbury Bancorp Inc for 102,478 shares. Fj Capital Management Llc owns 306,300 shares or 0.94% of their US portfolio. Moreover, Banc Funds Co Llc has 0.34% invested in the company for 387,580 shares. The Maryland-based Corbyn Investment Management Inc Md has invested 0.16% in the stock. Jacobus Wealth Management Inc., a Wisconsin-based fund reported 15,940 shares.